Undifferentiated carcinoma of the pancreas: Analysis of intermediate filament profile and Ki-ras mutations provides evidence of a ductal origin

Journal of Pathology

Volumn 185, Issue 1, 1998, Pages 53-60

  Hoorens, Anne ^a   Prenzel, Klaus ^b   Lemoine, Nicholas R ^b   Klöppel, Günter ^c  

^a FREE UNIVERSITY OF BRUSSELS   (Belgium)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c UNIVERSITY OF KIEL   (Germany)

Author keywords

Cytokeratin pattern; Ductal phenotype; Ki ras mutation; Osteoclast like giant cell tumour; Pancreatic tumours; Undifferentiated carcinoma; Vimentin

Indexed keywords

CD45 ANTIGEN; CD68 ANTIGEN; CYTOKERATIN; CYTOKERATIN 19; KERATIN; VIMENTIN;

ACINAR CELL CARCINOMA; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GIANT CELL TUMOR; HUMAN; HUMAN TISSUE; INTERMEDIATE FILAMENT; MALE; NEUROENDOCRINE TUMOR; ONCOGENE K RAS; OSTEOCLAST; PANCREAS ADENOCARCINOMA; PANCREAS CARCINOMA; PANCREAS DUCT; PRIORITY JOURNAL; PSEUDOTUMOR; SOLID TUMOR; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; FEMALE; GENES, RAS; GIANT CELL TUMORS; HUMANS; IMMUNOENZYME TECHNIQUES; INTERMEDIATE FILAMENTS; KERATINS; MALE; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; PANCREATIC NEOPLASMS; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 0031782102     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199805)185:1<53::AID-PATH45>3.0.CO;2-F     Document Type: Article

References (42)

1. Klöppel G. Pancreatic, non-endocrine tumours. In: Klöppel G, Heitz PU, eds. Pancreatic Pathology. Edinburgh: Churchill Livingstone, 1984; 79-113.
2. Trepeta RW, Mathur B, Lagin S, LiVolsi VA. Giant cell tumor ('osteoclastoma') of the pancreas: a tumor of epithelial origin. Cancer 1981; 48: 2022-2028.
3. Fischer HP, Altmannsberger M, Kracht J. Osteoclast-type giant cell tumour of the pancreas. Virchows Arch A [ Pathol Anat ] 1988; 412: 247-253.
4. Nojima T, Nakamura F, Ishikura M, Inoue K, Nagashima K, Kato H. Pleomorphic carcinoma of the pancreas with osteoclast-like giant cells. Int J Pancreatol 1993; 14: 275-281.
5. Cubilla AL, Fitzgerald PJ. Tumors of the Exocrine Pancreas. Washington, DC: Armed Forces Institute of Pathology, 1984.
6. Morohoshi T, Held G, Klöppel G. Exocrine pancreatic tumours and their histological classification. A study based on 167 autopsy and 97 surgical cases. Histopathology 1983; 7: 645-661.
7. Rosai J. Carcinoma of pancreas simulating giant cell tumor of bone. Electron-microscopic evidence of its acinar cell origin. Cancer 1968; 22: 333-344.
8. Suster S, Phillips M, Robinson MJ. Malignant fibrous histocytoma (giant cell type) of the pancreas. A distinctive variant of osteoclast-type giant cell tumor of the pancreas. Cancer 1989; 64: 2302-2308.
9. Goldberg RD, Michelassi F, Montag AG. Osteoclast-like giant cell tumor of the pancreas: immunophenotypic similarity to giant cell tumor of bone. Hum Pathol 1991; 22: 618-622.
10. Lewandrowski KB, Weston L, Dickersin GR, Rattner DW, Compton CC. Giant cell tumor of the pancreas of mixed osteoclastic and pleomorphic cell type: evidence for a histogenetic relationship and mesenchymal differentiation. Hum Pathol 1990; 21: 1184-1187.
11. Osborne M, van Essen G, Weber K, Klöppel G, Altmannsberger M. Differential diagnosis of gastrointestinal carcinomas by using monoclonal antibodies specific for individual keratin polypeptides. Lab Invest 1986; 55: 497-594.
12. Schüssler MH, Skoudy A, Ramaekers F, Real FX. Intermediate filaments as differentiation markers of normal pancreas and pancreas cancer. Am J Pathol 1992; 140: 559-568.
13. Santini D, Ceccarelli C, Martinelli GN, el al. Expression of intermediate filaments in normal and neoplastic exocrine pancreas. Zentralbl Pathol 1994; 140: 247-258.
14. Real FX, Vilá MR, Skoudy A, Ramaekers FCS, Corominas JM. Intermediate filaments as differentiation markers of exocrine pancreas. II. Expression of cytokeratins of complex and stratified epithelia in normal pancreas and in pancreas cancer. Int J Cancer 1993; 54: 720-727.
15. Hoorens A, Lemoine NR, McLellan E, et al. Pancreatic acinar cell carcinoma. An analysis of cell lineage markers, p53 expression, and Ki-ras mutation. Am J Parthol 1993; 143: 685-698.
16. Hruban RH, van Mansfield ADM, Offerhaus GJA, et al. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization. Am J Pathol 1993; 143: 545-554.
17. Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell 1988; 53: 549-554.
18. Smit VTBH, Boot AJM, Smits AMM, Focuren GJ, Cornelasse CJ, Bos JL. K-ras codon 12 mutations occur very frequently in pancreatic adenocarcinoma. Nucleic Acids Res 1988; 16: 7773-7782.
19. Grünewald K, Lyons J, Fröhlich A, et al. High frequency of Ki-ras codon 12 mutations in pancreatic adenocarcinomas. Int J Cancer 1989; 43: 1037-1041.
20. Lemoine NR, Jain S, Hughes CM, et al. Ki-ras oncogene activation in preinvasive pancreatic cancer. Gastroenterology 1992; 102: 230-236.
21. Levi S, Urbano-Ispizua A, Gill R, et al. Multiple k-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique. Cancer Res 1991; 51: 3497-3592.
22. Tschang TP, Garza-Garza R, Kissane JM. Pleomorphic carcinoma of the pancreas: an analysis of 15 cases. Cancer 1977; 39: 2114-2126.
23. Klöppel G, Solcia E, Longnecker DS, Capella C, Sobin LH. Histological Typing of Tumours of the Exocrine Pancreas. 2nd edn. WHO International Histological Classification of Tumours. Berlin: Springer-Verlag, 1996.
24. Hinze R, Knolle J, Holzhausen HJ, Wessel H, Bahn H, Moll R. Pankreas-tumoren mit Riesenzellen vom Osteoklastentyp - immunhistochemische, enzymhistochemische und ultrastrukturelle Untersuchungen. Verh Dtsch Ges Pathol 1996; 80: 668.
25. Klöppel G. Gene changes and pancreatic carcinoma: the significance of K-ras. Dig Surg 1994; 11: 164-169.
26. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982; 31: 11-24.
27. Herzig KH, Altmannsberger M, Fölsch UR. Intermediate filaments in rat pancreatic acinar tumors, human ductal carcinomas, and other gastrointestinal malignancies. Gastroenterology 1994; 106: 1326-1332.
28. Vilá MR, Balagué C, Real FX. Cytokeratins and mucins as molecular markers of cell differentiation and neoplastic transformation in the exocrine pancreas. Zentralbl Pathol 1994; 140: 225-235.
29. Janatpour KD, Teplitz R, Min B, Heffes C, Gumerlock P, Ruebner BH. Pancreatic tumors with osteoclastic and pleomorphic giant cells. Mod Pathol 1995; 8: 129 (Abstract 754)..
30. Gocke CD, Dabbs DJ, Benko FA, Silverman JF. KRAS oncogene mutations suggest a common histogenetic origin for pleomorphic giant cell tumor of the pancreas, osteoclastomy of the pancreas, and pancreatic duct adenocarcinoma. Hum Pathol 1997; 28: 80-83.
31. Egawa N, Maillet B, Schröder S, Foulis A, Mukai K, Klöppel G. Serous oligocystic and ill-demarcated adenoma of the pancreas: a variant of serous cystic adenoma. Virchows Arch 1994; 424: 13-17.
32. Moll R, Löwe A, Laufer J, Franke WW. Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol 1992; 140: 427-447.
33. Morohoshi T, Kanda M, Horie A, et al. Immunocytochemical markers of uncommon pancreatic tumors. Acinar cell carcinoma, pancreatoblastoma, and solid cystic (papillary-cystic) tumor. Cancer 1987; 59: 739-747.
34. Klimstra DS, Heffess CS, Oertel JE, Rosai J. Acinar cell carcinoma of the pancreas: a clinicopathologic study of 28 cases. Am J Surg Pathol 1992; 16: 815-837.
35. Pettinato G, Manivel JC, Ravetto C, et al. Papillary cystic tumor of the pancreas. A clinicopathologic study of 20 cases with cytologic, immunohistochemical, ultrastructural, and flow cytometric observations, and a review of the literature. Am J Clin Pathol 1992; 98: 478-488.
36. Klöppel G, Maurer R, Hofmann E, et al. Solid-cystic (papillary-cystic) tumours within and outside the pancreas in men: report of two patients. Virchows Arch A [Pathol Anat] 1991; 418: 179-183.
37. Haratake J, Horie A. An immunohistochemical study of sarcomatoid liver carcinomas. Cancer 1991; 68: 93-97.
38. Sessa F, Solcia E, Capella C, et al. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53, and c-erbB-2 abnormalities in 26 patients, Virchows Arch 1994; 425: 357-367.
39. Pellegata NS, Sessa F, Renault B, et al. K-ras and p53 gene mutations in pancreatic cancer: ductal and nonductal tumors progress through different genetic lesions. Cancer Res 1994; 54: 1556-1560.
40. Sessa F, Bonato M, Frigerio B, et al. Ductal cancers of the pancreas frequently express markers of gastrointestinal epithelial cells. Gastroenterology 1990; 98: 1655-1665.
41. Newbould MJ, Benbow EW, Sene A, Young M, Taylor TV. Adenocarcinoma of the pancreas with osteoclast-like giant cells: a case report with immunocytochemistry. Pancreas 1992; 7: 611-615.
42. Dworak O, Wittekind C, Koerfgen HP, Gall FP. Osteoclastic giant cell tumor of the pancreas. An immunohistological study and review of the literature. Pathol Res Pract 1993; 189: 228-231.